GC Biopharma Corp. (KRX:006280)

GC Biopharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,393,549	2,048,665	1,432,354	1,478,007	2,488,073	4,633,750
Market Cap Growth	43.03%	43.03%	-3.09%	-40.60%	-46.30%	206.42%
Enterprise Value	2,426,067	3,129,049	2,368,951	2,204,898	3,075,936	5,228,112
Last Close Price	122100.00	179500.00	124404.89	126814.61	210762.41	388984.60
PE Ratio	-	-	-	22.58	20.19	57.17
Forward PE	37.04	87.99	47.35	21.09	25.00	33.91
PS Ratio	0.83	1.22	0.88	0.86	1.62	3.08
PB Ratio	1.11	1.38	0.93	0.94	1.66	3.65
P/TBV Ratio	1.94	1.94	1.34	1.33	2.31	4.30
P/FCF Ratio	-	-	24.17	105.17	-
P/OCF Ratio	-	-	12.40	19.75	128.81
PEG Ratio	1.35	1.35	1.35	1.35	1.20	0.45
EV/Sales Ratio	1.44	1.86	1.46	1.29	2.00	3.48
EV/EBITDA Ratio	21.22	27.67	21.57	15.12	23.73	52.82
EV/EBIT Ratio	72.88	97.66	69.86	27.32	41.72	104.18
EV/FCF Ratio	-28.39	-	-	36.05	130.02	-
Debt / Equity Ratio	0.56	0.56	0.47	0.37	0.40	0.45
Debt / EBITDA Ratio	7.32	7.32	6.59	3.95	4.68	5.72
Debt / FCF Ratio	-	-	-	9.41	25.64	-
Asset Turnover	0.62	0.62	0.63	0.69	0.67	0.73
Inventory Turnover	1.90	1.90	2.38	2.52	2.28	2.52
Quick Ratio	0.55	0.55	0.58	0.96	1.13	1.15
Current Ratio	1.56	1.56	1.20	1.81	1.97	1.92
Return on Equity (ROE)	-2.82%	-2.82%	-1.27%	4.53%	9.89%	7.26%
Return on Assets (ROA)	0.74%	0.74%	0.82%	2.02%	2.00%	1.53%
Return on Capital (ROIC)	0.88%	0.88%	0.96%	2.38%	2.34%	1.79%
Return on Capital Employed (ROCE)	1.60%	1.60%	1.90%	4.10%	3.90%	3.20%
Earnings Yield	-1.89%	-1.28%	-1.86%	4.43%	4.95%	1.75%
FCF Yield	-6.13%	-4.17%	-5.90%	4.14%	0.95%	-1.01%
Dividend Yield	1.20%	0.84%	-	-	-	-
Payout Ratio	0.00%	-	-	36.65%	15.02%	15.69%
Buyback Yield / Dilution	-	-	-125.85%	55.72%	-
Total Shareholder Return	1.20%	0.84%	-	-125.85%	55.72%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.